Is Medibios Laboratories a good quality company?

Data is not available for this company.

What is Medibios Laboratories share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Medibios Laboratories?

The latest standalone P/E ratio of Medibios Laboratories as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Medibios Laboratories?

The latest standalone P/B ratio of Medibios Laboratories as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Medibios Laboratories?

The 52-week high of Medibios Laboratories is Rs. 0.00 and the 52-week low is Rs. 0.00.

Medibios Laboratories Ltd - Stock Valuation and Financial Performance

Name: Medibios Laboratories
Brand: Medibios Laboratories

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Medibios Labs.

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Medibios Labs.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
ROCE % ⓘ	10.6%	13.6%	16.7%	19.7%	25.5%	19%	-
Value Creation Index ⓘ	-0.2	0.0	0.2	0.4	0.8	0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	32.9	35.9	37.2	40.1	49.4	59.7	60
Sales YoY Gr.	-	9.1%	3.5%	7.8%	23.4%	20.7%	-
Adj EPS ⓘ	1.3	1.9	3.4	4.8	7.8	7.8	7.8
YoY Gr.	-	42.1%	81%	39.8%	63.4%	0.4%	-
BVPS (₹) ⓘ	11.3	13.2	16.5	20.8	28.7	37.7	37.7
Adj Net Profit ⓘ	0.9	1.3	2.4	3.4	5.6	5.6	0
Cash Flow from Ops. ⓘ	4.5	3	2.6	5.3	4.9	3.1	-
Debt/CF from Ops. ⓘ	1.9	2.5	3.4	1.7	1.5	3.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	12.6%	17.1%	20.7%
Adj EPS ⓘ	NA	42.6%	31.9%	0.4%
BVPSⓘ	NA	27.1%	31.8%	31.3%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
Return on Equity % ⓘ	11.7	15.4	23.1	25.7	31.6	23.6	20.8
Op. Profit Mgn % ⓘ	11	11.9	15.4	21.6	23.2	17.7	NAN
Net Profit Mgn % ⓘ	2.9	3.7	6.5	8.5	11.2	9.3	0
Debt to Equity ⓘ	1.1	0.8	0.8	0.6	0.4	0.4	-
Working Cap Days ⓘ	0	131	151	143	124	154	0
Cash Conv. Cycle ⓘ	0	34	50	49	28	60	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Medibios Laboratories Ltd.

	Standalone	Consolidated
TTM EPS (₹)	7.8	-
TTM Sales (₹ Cr.)	59.7	-
BVPS (₹.) ⓘ	37.7	-
Reserves (₹ Cr.) ⓘ	20	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	48.8

Management X-Ray of Medibios Labs.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Medibios Labs.

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Medibios Labs.

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Sales	32.89	35.88	37.15	40.06	49.42	59.65
Operating Expenses ⓘ	29.27	31.62	31.41	31.68	38	49.10
Manufacturing Costs	8.24	8.96	8.87	10.15	3.14	0
Material Costs	17.28	17	16.10	14	21.24	33.50
Employee Cost	2.36	2.79	3.65	4	4.85	5.54
Other Costs ⓘ	1.38	2.87	2.80	3.54	8.77	10.06
Operating Profit ⓘ	3.61	4.25	5.73	8.38	11.42	10.56
Operating Profit Margin (%)	11.0%	11.9%	15.4%	20.9%	23.1%	17.7%
Other Income ⓘ	0.19	0.34	0.08	0.02	0.03	0.30
Interest ⓘ	1.20	1.35	1.01	1.40	1.41	0.83
Depreciation ⓘ	1.19	1.24	1.17	2.05	1.68	2.30
Exceptional Items ⓘ	0	0	0	0	0	0
Profit Before Tax ⓘ	1.41	2	3.63	4.96	8.37	7.73
Tax ⓘ	0.47	0.66	1.20	1.76	2.85	2.16
Profit After Tax	0.94	1.34	2.43	3.21	5.52	5.57
PAT Margin (%)	2.9%	3.7%	6.5%	8.0%	11.2%	9.3%
Adjusted EPS (₹)	1.3	1.9	3.4	4.5	7.8	7.8
Dividend Payout Ratio (%)	4%	3%	2%	2%	1%	1%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Equity and Liabilities
Shareholders Fund	8.06	9.34	11.70	14.76	20.39	26.76
Share Capital ⓘ	2.37	2.37	7.10	7.10	7.10	7.10
Reserves ⓘ	5.69	6.97	4.59	7.66	13.29	19.66
Minority Interest	0	0	0	0	0	0
Debt	7.85	6.68	8.39	7.78	7.11	10.45
Long Term Debt	1.12	0.02	1.49	4.61	3.22	4.24
Short Term Debt	6.73	6.66	6.90	3.17	3.88	6.21
Trade Payables	5.50	6.88	7.22	4.74	7.79	8.67
Others Liabilities ⓘ	8.46	7.99	9.63	7.14	7.10	6.51
Total Liabilities ⓘ	29.86	30.89	36.93	34.42	42.39	52.40
Fixed Assets
Gross Block	23.18	24.37	26.77	28.73	32	34.94
Accumulated Depreciation	7.47	8.47	9.51	10.43	12.16	14.28
Net Fixed Assetsⓘ	15.72	15.90	17.26	18.30	19.84	20.66
CWIP ⓘ	0	0	0	0	0	0
Investmentsⓘ	0	0	1.24	1.24	1.24	1.27
Inventories	5.26	4.61	5.63	3.58	6.44	11.61
Trade Receivables	5.09	7.39	10.13	8.01	11.46	14.63
Cash Equivalents	0.99	0.57	0.26	0.14	0.22	0.02
Others Assetsⓘ	2.81	2.42	2.41	3.14	3.19	4.20
Total Assets ⓘ	29.86	30.89	36.93	34.42	42.39	52.40

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Cash Flow From Operating Activity ⓘ	4.50	3	2.62	5.30	4.89	3.05
PBT ⓘ	1.41	2	3.63	5.03	8.37	7.73
Adjustment ⓘ	2.30	2.25	2.10	3.70	1.60	2.08
Changes in Working Capital ⓘ	1.21	-0.65	-1.96	-1.48	-5.07	-6.76
Tax Paid ⓘ	-0.42	-0.60	-1.16	-1.88	0	0
Cash Flow From Investing Activity ⓘ	-2.05	-0.87	-3.57	-3.35	-3.07	-3.64
Capex	-2.13	-1.19	-2.40	-3.08	-3.09	-2.94
Net Investments	0	0	-1.24	0	0	0
Others ⓘ	0.08	0.33	0.07	-0.27	0.02	-0.70
Cash Flow From Financing Activityⓘ	-1.95	-2.56	0.64	-2.07	-1.74	0.39
Net Proceeds from Shares ⓘ	0	0	4.74	0	0	0
Net Proceeds from Borrowing ⓘ	-0.36	-1.09	1.47	3.12	0	0
Interest Paid ⓘ	-1.20	-1.35	-1.01	-1.40	0	0
Dividend Paid ⓘ	-0.04	-0.04	-0.06	-0.06	-0.08	-0.08
Others ⓘ	-0.34	-0.07	-4.49	-3.73	-1.65	0.47
Net Cash Flow ⓘ	0.50	-0.42	-0.31	-0.12	0.08	-0.20

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Ratios
ROE (%)	11.71	15.4	23.1	24.23	31.39	23.63
ROCE (%)	15.56	19.92	24.74	28.56	38.09	26.44
Asset Turnover Ratio	1.15	1.26	1.16	1.18	1.37	1.29
PAT to CFO Conversion(x)	4.79	2.24	1.08	1.65	0.89	0.55
Working Capital Days
Receivable Days	54	59	81	79	67	78
Inventory Days	56	47	47	40	35	54
Payable Days	116	133	160	156	108	90

Medibios Laboratories Ltd Stock News

Medibios Laboratories Ltd FAQs

What is the share price of Medibios Labs.?

Company share prices are keep on changing according to the market conditions. The closing price of Medibios Labs. on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Medibios Labs.?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Medibios Labs. stood at ₹0.00.